References
- Cardelli M. The epigenetic alterations of endogenous retroelements in aging. Mech Ageing Dev. 2018;174:30–46. doi:https://doi.org/10.1016/j.mad.2018.02.002
- Ciccarone F, Tagliatesta S, Caiafa P, Zampieri M. DNA methylation dynamics in aging: how far are we from understanding the mechanisms. Mech Ageing Dev. 2018;174:3–17. doi:https://doi.org/10.1016/j.mad.2017.12.002
- Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14(10):576–590. doi:https://doi.org/10.1038/s41574-018-0059-4
- Liguori I, Russo G, Curcio F, Bulli G, Aran L, Della-Morte D, Gargiulo G, Testa G, Cacciatore F, Bonaduce D, et al. Oxidative stress, aging, and diseases. Clin Interv Aging. 2018;13:757–772. doi:https://doi.org/10.2147/CIA.S158513
- Veisani Y, Jenabi E, Khazaei S, Nematollahi S. Global incidence and mortality rates in pancreatic cancer and the association with the Human Development Index: decomposition approach. Public Health. 2018;156:87–91. doi:https://doi.org/10.1016/j.puhe.2017.12.015
- Higuera O, Ghanem I, Nasimi R, Prieto I, Koren L, Feliu J. Management of pancreatic cancer in the elderly. World J Gastroenterol. 2016;22(2):764–775. doi:https://doi.org/10.3748/wjg.v22.i2.764
- Younus H. Therapeutic potentials of superoxide dismutase. Int. J. Health Sci. 2018;12:88–93.
- McMahon M, Itoh K, Yamamoto M, Hayes JD. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J Biol Chem. 2003;278(24):21592–21600. doi:https://doi.org/10.1074/jbc.M300931200
- Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999;13(1):76–86. doi:https://doi.org/10.1101/gad.13.1.76
- Cleasby A, Yon J, Day PJ, Richardson C, Tickle IJ, Williams PA, Callahan JF, Carr R, Concha N, Kerns JK, et al. Structure of the BTB domain of Keap1 and its interaction with the triterpenoid antagonist CDDO. PloS One. 2014;9(6):e98896. doi:https://doi.org/10.1371/journal.pone.0098896
- Baird L, Dinkova-Kostova AT. The cytoprotective role of the Keap1-Nrf2 pathway. Arch Toxicol. 2011;85(4):241–272. doi:https://doi.org/10.1007/s00204-011-0674-5
- Baird L, Llères D, Swift S, Dinkova-Kostova AT. Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex. Proc Natl Acad Sci U S A. 2013;110(38):15259–15264. doi:https://doi.org/10.1073/pnas.1305687110
- Dinkova-Kostova AT, Liby KT, Stephenson KK, Holtzclaw WD, Gao X, Suh N, Williams C, Risingsong R, Honda T, Gribble GW, et al. Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress. Proc Natl Acad Sci U S A. 2005;102(12):4584–4589. doi:https://doi.org/10.1073/pnas.0500815102
- Hayes JD, McMahon M, Chowdhry S, Dinkova-Kostova AT. Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway. Antioxid Redox Signal. 2010;13(11):1713–1748. doi: https://doi.org/10.1089/ars.2010.3221.
- Cuadrado A, Kügler S, Lastres-Becker I. Lastres-Beckera I: pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy. Redox Biol. 2018;14:522–534. doi:https://doi.org/10.1016/j.redox.2017.10.010
- González-Vallinas M, González-Castejón M, Rodríguez-Casado A, Ramírez de Molina A. Dietary phytochemicals in cancer prevention and therapy: a complementary approach with promising perspectives. Nutr Rev. 2013;71(9):585–599. doi:https://doi.org/10.1111/nure.12051
- Krajka-Kuźniak V, Paluszczak J, Szaefer H, Baer-Dubowska W. Betanin, a beetroot component, induces nuclear factor erythroid-2-related factor 2-mediated expression of detoxifying/antioxidant enzymes in human liver cell lines. Br J Nutr. 2013;110(12):2138–2149. doi:https://doi.org/10.1017/S0007114513001645
- Krajka-Kuźniak V, Paluszczak P, Baer-Dubowska W. Xanthohumol induces phase II enzymes via Nrf2 in human hepatocytes in vitro. Toxicol in Vitro. 2013;27(1):149–156. doi:https://doi.org/10.1016/j.tiv.2012.10.008
- Ju H-Q, Gocho T, Aguilar M, Wu M, Zhuang Z-N, Fu J, Yanaga K, Huang P, Chiao PJ. Mechanisms of overcoming intrinsic resistance to gemcitabine in pancreatic ductal adenocarcinoma through the redox modulation. Mol Cancer Ther. 2015;14(3):788–798. doi:https://doi.org/10.1158/1535-7163.MCT-14-0420
- Saw CLL, Guo Y, Yang AY, Paredes-Gonzalez X, Ramirez C, Pung D, Kong A-NT. The berry constituents quercetin, kaempferol, and pterostilbene synergistically attenuate reactive oxygen species: involvement of the Nrf2-ARE signaling pathway. Food Chem Toxicol. 2014;72:303–311. doi:https://doi.org/10.1016/j.fct.2014.07.038
- Krajka-Kuźniak V, Paluszczak J, Baer-Dubowska W. The Nrf2-ARE signaling pathway: an update on its regulation and possible role in cancer prevention and treatment. Pharmacol Rep. 2017;69(3):393–402. doi:https://doi.org/10.1016/j.pharep.2016.12.011
- Probst BL, McCauley L, Trevino I, Wigley WC, Ferguson DA. Cancer cell growth is differentially affected by constitutive activation of NRF2 by KEAP1 deletion and pharmacological activation of NRF2 by the synthetic triterpenoid, RTA 405. PloS One. 2015;10(8):e0135257. doi:https://doi.org/10.1371/journal.pone.0135257
- McCubrey JA, Lahair MM, Franklin RA. Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid Redox Signal. 2006;8(9–10):1775–1789. doi:https://doi.org/10.1089/ars.2006.8.1775
- Kang KW, Lee SJ, Park JW, Kim SG. Phosphatidylinositol 3-kinase regulates nuclear translocation of NF-E2-related factor 2 through actin rearrangement in response to oxidative stress. Mol Pharmacol. 2002;62(5):1001–1010. doi:https://doi.org/10.1124/mol.62.5.1001
- Jain AK, Jaiswal AK. GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2. J Biol Chem. 2007;282(22):16502–16510. doi:https://doi.org/10.1074/jbc.M611336200
- Salazar M, Rojo AI, Velasco D, de Sagarra RM, Cuadrado A. Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2. J Biol Chem. 2006;281(21):14841–14851. doi:https://doi.org/10.1074/jbc.M513737200
- Joo MS, Kim WD, Lee KY, Kim JH, Koo JH, Kim SG. AMPK facilitates nuclear accumulation of Nrf2 by phosphorylating at serine 550. Mol Cell Biol. 2016;36(14):1931–1942. doi:https://doi.org/10.1128/MCB.00118-16
- Varì R, D’Archivio M, Filesi C, Carotenuto S, Scazzocchio B, Santangelo C, Giovannini C, Masella R. Protocatechuic acid induces antioxidant/detoxifying enzyme expression through JNK-mediated Nrf2 activation in murine macrophages. J Nutr Biochem. 2011;22(5):409–417. doi:https://doi.org/10.1016/j.jnutbio.2010.03.008
- Zhou J, Li LU, Fang LI, Xie H, Yao W, Zhou X, Xiong Z, Wang LI, Li Z, Luo F. Quercetin reduces cyclin D1 activity and induces G1 phase arrest in HepG2 cells. Oncol Lett. 2016;12(1):516–522. doi: doi:https://doi.org/10.3892/ol.2016.4639
- Qin S, Deng F, Wu W, Jiang L, Yamashiro T, Yano S, Hou D-X. Baicalein modulates Nrf2/Keap1 system in both Keap1-dependent and Keap1-independent mechanisms. Arch Biochem Biophys. 2014;559:53–61. doi:https://doi.org/10.1016/j.abb.2014.03.011
- Lawrence B, Findlay M. Systemic therapy for metastatic pancreatic adenocarcinoma. Ther Adv Med Oncol. 2010;2(2):85–106. doi:https://doi.org/10.1177/1758834009357188